Sleep genes;Genes del sueño

Revista de Neurologia

Volumn 48, Issue 4, 2009, Pages 199-206

  Prospero Garcia O ^a,c   Guzman K ^a   Mendez Diaz M ^a   Herrera Solis A ^a   Ruiz Contreras, A ^b  

^a Facultad de Medicina   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Genes; Insomnia; Narcolepsy; Parasomnias; Sleep; Twins

Indexed keywords

ANANDAMIDE; CORTISTATIN; ENDOCANNABINOID; HLA DQB1 ANTIGEN; OREXIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; NEUROPEPTIDE; OREXINS; SIGNAL PEPTIDE;

GENE; GENE CONTROL; GENE EXPRESSION; GENETIC LOAD; HUMAN; INSOMNIA; NARCOLEPSY; NONHUMAN; REVIEW; SLEEP DISORDER; SLEEP GENE; TWINS; ANIMAL; GENETICS; MAMMAL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SLEEP;

ANIMALS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAMMALS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; SLEEP; SLEEP DISORDERS;

EID: 62649172734     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4804.2008516     Document Type: Review

References (76)

1. Zepelin H. Mammalian sleep. In Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. Philadelphia: W.B. Saunders; 1994. p. 69-80.
2. Siegel JM, Manger PR, Nienhuis R, Fahringer HM, Pettigrew JD. The echidna tachyglossus aculeatus combines REM and Non-REM aspects in a single sleep states: implications for the evolution of sleep. J Neurosci 1996; 16: 3500-6.
3. Jouvet-Monnier D, Astic L, Lacote D. Ontogenesis of the states of sleep in rat, cat and guinea pig during the first postnatal month. Dev Psychobiol 1968; 2: 216-39.
4. Roffwarg HP, Muzio JN, Dement WC. Ontogenetic development of the human sleep-dream cycle. Science 1966; 152: 604-19.
5. Dew MA, Hoch CC, Buysee DJ, Monk T, Begley AE, Houck PR, et al. Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med 2003; 65: 63-73.
6. García-García F, Drucker-Colín R. Endogenous and exogenous factors on sleep-wake cycle regulation. Prog Neurobiol 1999; 58: 297-314.
7. Brailowsky S, Prospero-García O, Salas-Domínguez J, Álvarez-Rueda M. Identical twin studies indicate genetic influence on human sleep patterns. Neuroscience 1992; 1: 83-8.
8. Kronholm E, Aunola S, Hyyppa MT, Kaitsaari M, Koskenvuo M, Mattlar CE, et al. Sleep in monozygotic twin pairs discordant for obesity. J Appl Physiol 1996; 80: 14-9.
9. Mackiewicz M, Paigen B, Naidoo N, Pack AI. Analysis of the QTL for sleep homeostasis in mice: Homer 1a is likely a candidate. Physiol Genomics 2008; 33: 91-9.
10. Maret S, Dorsaz S, Gurcel L, Pradervand S, Petit B, Pfister C, et al. Homer 1a is a core brain molecular correlate of sleep loss. Proc Natl Acad Sci U S A 2007; 104: 20090-5.
11. Hublin C, Kaprio J, Partinen M, Koskenvuo M. Nightmares: familial aggregation and association with psychiatric disorders in a nationwide twin cohort. Am J Med Genet 1999; 88: 329-36.
12. Hublin C, Kaprio J, Partinen M, Koskenvuo M. Sleeptalking in twins: epidemiology and psychiatric comorbidity. Behav Genet 1998; 28: 289-98.
13. Hublin C, Kaprio J, Partinen M, Heikkila K, Koskenvuo M. Prevalence and genetics of sleepwalking: a population-based twin study. Neurology 1997; 48: 177-81.
14. Lecendreux M, Bassetti C, Dauvillers Y, Mayer G, Neidhart E, Tafti M. HLA and genetic susceptibility to sleepwalking. Mol Psychiatr 2003; 8: 114-7.
15. Ferini-Strambi L, Calori G, Oldani A, Della Marca G, Zucconi M, Castronovo V, et al. Snoring in twins. Respir Med 1995; 89: 337-40.
16. Adickes ED, Buehler BA, Sanger WG. Familial lethal sleep apnea. Hum Genet 1986; 73: 39-43.
17. Khalifa MM, Flavin MA, Wherrett BA. Congenital central hypoventilation syndrome in monozygotic twins. J Pediatr 1988; 113: 853-5.
18. Buriokata N, Koyanagi S, Endo M, Takata M, Fukuoka Y, Miyata M, et al. Clock gene dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir 2008; 32: 105-12.
19. Camfield CS, Camfield PR, Finley J. Screening of subsequent siblings of children who die of sudden infant death syndrome. Am J Dis Child 1987; 141: 807-10.
20. Ko CH, Takahashi JS. Molecular components of the mammalian circadian clock. Hum Mol Genet 2006; 15: 271-7.
21. Hamet P, Tremblay J. Genetics of the sleep-wake cycle and its disorders. Metab Clin Exp 2006; 55 (Suppl 2): S7-12.
22. Toh KL, Jones KR, He Y, Eide EJ, Hinz WA, Virshup DM, et al. An hPer2 phosphorilation site mutation in familial advanced sleep phase syndrome. Science 2001; 291: 1040-3.
23. Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, Saigoh N, et al. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 2005; 434: 640-4.
24. Hohjoh H, Takasu M, Shishikura K, Takahashi Y, Honda Y, Tokunaga K. Significant association of the arylalkylamine N-acetyltransferase gene with delayed sleep phase syndrome. Neurogenetics 2003; 4: 151-3.
25. Archer SN, Robilliard DL, Skene DJ, Smits M, Williams A, Arendt J, et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed phase syndrome and extreme diurnal preference. Sleep 2003; 26: 413-5.
26. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character inventory (TCI). Arch Gen Psychiatry 1993; 50: 975-90.
27. De Saint-Hilaire Z, Straub J, Pelissolo A. Temperament and character in primary insomnia. Eur Psychiatr 2005; 20: 188-92.
28. Basta M, Chrousos GP, Vela-Bueno A, Vgontzas AN. Chronic insomnia and stress system. Sleep Med Clin 2007; 2: 279-91.
29. Koh K, Joiner WJ, Wu MN, Yue Z, Smith CJ, Sehgal A. Identification of SLEEPLESS, a sleep promoting factor. Science 2008; 321: 334-7.
30. Reder AT, Mednick AS, Brown P, Spire JP, Van Cauter E, Wollmann RL, et al. Clinical and genetic studies of fatal familial insomnia. Neurology 1995; 45: 1068-75.
31. Fiorino A. Sleep, genes and death: fatal familial insomnia. Brain Res Rev 1996; 22: 258-64.
32. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, et al. Evidence for the conformation of the pathologic isoform of the prion protein encepherin and propagating prion diversity. Science 1996; 274: 2079-82.
33. Goldfarb LG, Petersen RB, Tabaton M, Brown P, LeBlanc AC, Montagna P, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992; 258: 806-8.
34. Medori R, Tritschler HJ, LeBlanc A, Villare F, Manetto V, Chen HY, et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 1992; 326: 444-9.
35. Prusiner SB. Molecular of biology of prion diseases. Science 1991; 152: 1515-22.
36. Westaway D, Cooper C, Turner S, Da Costa M, Carlson GA, Prusiner SB. Structure and polymorphism of the mouse prion protein gene. Proc Natl Acad Sci U S A 1994; 91: 6418-22.
37. Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M, Rülicke T, et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 1996; 380: 639-42.
38. Franken P, Tobler I, Bornely AA. Sleep homeostasis in the rat: simulation of the time course of EEG slow wave activity. Neurosci Lett 1991; 130: 141-4.
39. Huber R, Deboer T, Tobler I. Prion protein: a role in sleep regulation. J Sleep Res 1999; 8: 30-6.
40. Mignot E, Nishino S. Narcolepsy. In Lydic R, Baghdoyan HA, eds. Handbook of behavioral state control. Cellular and molecular mechanisms. Boca Raton: CRC Press; 1999. p. 129-41.
41. De Vicente Álvarez-Manzaneda EE. Avances en el diagnóstico y tratamiento del síndrome de narcolepsia-cataplejía. Rev Neurol 2008; 46: 550-6.
42. Douglass AB, Harris L, Pazderka F. Monozygotic twins concordant for the narcoleptic syndrome. Neurology 1989; 39: 140-1.
43. Guilleminault C, Mignot E, Grumet FC. Familial patterns of narcolepsy. Lancet 1989; 2: 1376-9.
44. Partinen M, Hublin C, Kaprio J, Koskenvuo M, Guilleminault C. Twin studies in narcolepsy. Sleep 1994; 17: S13-6.
45. Reiss AL, Hoeft F, Tenforde AS, Chen W, Mobbs D, Mignot EJ. Anomalous hypothalamic responses to humor in cataplexy. PLoS One 2008; 3: e2225.
46. Pollmächer T, Schulz H, Geisler P, Kiss E, Albert ED, Schwarzfischer F. DR2-positive monozygotic twins discordant for narcolepsy. Sleep 1990; 13: 336-43.
47. Nakayama J, Miura M, Honda M, Miki T, Honda Y, Arinami T. Linkage of human narcolepsy with HLA association to chromosome 4p13-q21. Genomics 2000; 65: 84-6.
48. Dauvilliers Y, Blouin JL, Neidhart E, Carlander B, Eliaou JF, Antonarakis SE, et al. A narcolepsy susceptibility locus maps to a 3 Mb region of chromosome 21q. Ann Neurol 2004; 56: 382-8.
49. Miyagawa T, Kawashima M, Nishida N, Ohashi J, Kimura R, Fujimoto A, et al. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet 2008: 40: 1324-8.
50. Foutz AS, Mitler MM, Cavalli-Sforza LL, Dement WC. Genetic factors in canine narcolepsy. Sleep 1979; 1: 413-21.
51. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999; 98: 437-51.
52. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999; 98: 365-76.
53. Takahashi J. Narcolepsy genes wake up the sleep field. Science 1999; 285: 2076-7.
54. De Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hipocretins: Hypothalamus specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998; 95: 322-7.
55. Del Cid-Pellitero E, Garzón M. El sistema de neurotransmisión hipocretinérgico/orexinérgico en la regulación de los estados de vigilia y sueño. Rev Neurol 2007; 45: 482-90.
56. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexin and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-85.
57. Sakurai T, Moriguchi T, Furuya K, Kajiwara N, Nakamura T, Yanagisawa M, et al. Structure and function of human prepro-orexin gene. J Biol Chem 1999; 274: 17771-6.
58. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355: 39-40.
59. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, et al. A mutation in a case of early onset narcolepsy and a generalizaed absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6: 991-7.
60. Taheri S, Sunter D, Dakin C, Moyes S, Seal L, Gardiner J, et al. Diurnal variations in orexin A and prepro-orexin mRNA in the rat central nervous system. Neurosci Lett 2000; 279: 109-12.
61. Iranzo A, Aparicio J. A lesson from anatomy: focal brain lesions causing REM sleep behavior disorder. Sleep Med 2008 [Epub ahead of print]; doi:10.1016/j.sleep.2008.03.005.
62. Schenck CH, Garcia-Rill E, Segall M, Noreen H, Mahowald MW. HLA class II genes associated with REM sleep behavior disorder. Ann Neurol 1996; 39: 261-3.
63. Pichler I, Marroni F, Volpato CB, Gusella JF, Klein C, Casari G, et al. Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a south Tyrolean population isolate. Am J Hum Genet 2006; 79: 716-23.
64. Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007; 39: 1000-6.
65. Schormair B, Kemlik D, Roeske D, Eckstein G, Xiong L, Lichtner P, et al. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet 2008; 40: 946-8.
66. De Lecea L, Criado JR, Prospero-García Ó, Gautvik KM, Schweitzer P, Danielson PE, et al. A cortical neuropetide with neuronal depressant and sleep-modulating properties. Nature 1996; 381: 242-5.
67. Bourgin P, Fabre V, Huitrón-Resendiz S, Henriksen SJ, Prospero-García O, Criado JR, et al. Cortistatin promotes and negatively correlates with slow-wave sleep. Eur J Neurosci 2007; 26: 729-38.
68. Méndez-Díaz M, Erwin L, Gómez-Chavarín M, Jiménez-Anguiano A, Cabeza R, Murillo-Rodríguez E, et al. Cortistatin modultes memory evocation in rats. Eur J Pharmacol 2005; 507: 21-8.
69. De Lecea L, Ruiz-Lozano P, Danielson PE, Peelle-Kirley J, Foye PE, Frankel WN, et al. Cloning, mRNA expression and chromosomal mapping of mouse and human preprocortistatin. Genomics 1997; 42: 499-506.
70. De Lecea L, Sutcliffe JG. Peptides, sleep and cortistatin. Mol Psychiatry 1996; 1: 349-51.
71. Siehler S, Seuwen K, Hoyer D. [125]Tyr10-cortistatin14 labels all five somatostatin receptors. Arch Pharmacol 1998; 357: 483-9.
72. Wan M, Cravatt BF, Ring HZ, Zhang X, Francke U. Conserved chromosomal location and genomic structure of human and mouse fattyacid amide hydrolase genes and evaluation of clasper as a candidate neurological mutation. Genomics 1998; 54: 408-14.
73. Prospéro-García O, Navarro L, Murillo-Rodríguez E, Sánchez-Alavez M, Guzmán-Marín R, Méndez-Díaz M, et al. Cellular and molecular changes occurring during REM sleep. In Mallick BN, Inoue S, eds. Rapid eye movement sleep. New Delhi: Narosa Publishing House; 1999. p. 367-81.
74. Valatx JL, Bugat R, Jouvet M. Genetic studies of sleep in mice. Nature 1972; 238: 226-7.
75. Friedmann J. A diallel analysis of the genetic underpinnings of mouse sleep. Physiol Behav 1974; 12: 169-75.
76. Franken P, Malafosse A, Tafti M. Genetic determinants of sleep regulation in inbred mice. Sleep 1999; 22: 155-69.